Full text
| |
| Author(s): |
Luis Francisco Zirnberger Batista
Total Authors: 1
|
| Document type: | Doctoral Thesis |
| Press: | São Paulo. |
| Institution: | Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB/SDI) |
| Defense date: | 2008-08-04 |
| Examining board members: |
Carlos Frederico Martins Menck;
Anamaria Aranha Camargo;
Edison Luiz Durigon;
Alicia Juliana Kowaltowski;
Luis Fernando Lima Reis
|
| Advisor: | Carlos Frederico Martins Menck |
| Field of knowledge: | Biological Sciences - Genetics |
| Indexed in: | Banco de Dados Bibliográficos da USP-DEDALUS; Biblioteca Digital de Teses e Dissertações - USP |
| Location: | Universidade de São Paulo. Biblioteca do Instituto de Ciências Biomédicas; T-ICB BMM QW4; 333mi |
| Abstract | |
Induction of DNA lesions leads to several different endpoints in mammalian cells, such as replication blockage, activation of DNA repair pathways, mutagenesis and induction of apoptosis. Although apoptosis induction might be involved in deleterious conditions, it can also bring benefit, as for instance to avoid the uncontrolled propagation of a mutated cell. The molecular mechanisms leading to apoptosis induction by DNA damage still remain largely under covered. This work provides evidence that the replication of damaged -DNA works as a trigger for UV-induced apoptosis. Surprisingly, even in DNA repair-deficient cells the inhibition of damaged-DNA replication is able to protect from apoptosis induction. This work also indicates that the chemotherapeutical agents Temozolomide, ACNU and BCNU are able to trigger apoptosis in human glioma cells, in a manner that is tightly controlled by the tumor suppressor gene p53, which depending upon the agent used will determine if the lesion will be removed by DNA repair or if cells will trigger apoptosis. (AU) | |